yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
2
Q38955668-D7383048-4124-4B64-8F84-462F199B32CF
Q38955668-D7383048-4124-4B64-8F84-462F199B32CF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38955668-D7383048-4124-4B64-8F84-462F199B32CF
Comparison of the new Japanese legislation for expedited approval of regenerative medicine products with the existing systems in the USA and European Union.
P2860
Q38955668-D7383048-4124-4B64-8F84-462F199B32CF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38955668-D7383048-4124-4B64-8F84-462F199B32CF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
74c1e1f0f2352c9edd6a0872e9e5929eb2924493
P2860
Development times, clinical testing, postmarket follow-up, and safety risks for the new drugs approved by the US food and drug administration: the class of 2008.